Concepedia

Nicholas B. Vera

NB

Statistics

Publications

14

Citations

1.1K

H-Index

14

Active since

2014

Affiliations

Pfizer (United States)(Current)

University of California, San Francisco

University of California, Berkeley

Yale University

Howard Hughes Medical Institute

Nicholas B. Vera is an author at Pfizer (United States) specializing in biochemistry, life sciences, and lipid metabolism.

ORCID

Publications per year

2014–2021

14

Publications

14

Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice

Camella G. Wilson, Jennifer L. Tran, Derek M. Erion et al. · Endocrinology · 2015 · 466 citations · Full text

, , +16

Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells

Jessica Jones, William P. Esler, Rushi S. Patel et al. · PLoS ONE · 2017 · 112 citations · Full text

, , +17

Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction

Jemy A. Gutierrez, Wei Liu, Sylvie Perez et al. · Molecular Metabolism · 2021 · 84 citations · Full text

, , +16

Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)

Kim Huard, Janice A. Brown, Jessica Jones et al. · Scientific Reports · 2015 · 70 citations · Full text

, , +11

Adipocyte OGT governs diet-induced hyperphagia and obesity

Min‐Dian Li, Nicholas B. Vera, Yunfan Yang et al. · Nature Communications · 2018 · 63 citations · Full text

, , +17

1–5 of 14